Pure Global
NCT05750381

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

BLIS Technologies Limited·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
Micrococcus luteus Blis Q24 balm
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
BLIS Technologies Limited
Location
Dunedin, New Zealand
Timeline & enrollment
Phase
N/A
Start date
Jan 24, 2023
End date
Apr 12, 2023
Enrollment
20 participants
Primary outcome

Change in microbial composition on skin following application of Micrococcus luteus Q24 in balm from Day 0 (baseline) to 11 days,Change in microbial composition on skin following application of placebo balm from Day 0 (baseline) to 11 days,Change in microbial composition on skin post 10 days application of Micrococcus luteus Q24 in balm from Day 11 (baseline) to 18 days.,Change in microbial composition on skin post 10 day application application of placebo balm from Day 11 (baseline) to 18 days,Change in skin quality parameters following topical application Micrococcus luteus Q24 from Day 0 (baseline) to 11 days,Change in skin quality parameters following topical application of placebo balm from Day 0 (baseline) to 11 days,Change in skin quality parameters post 10 days application of Micrococcus luteus Q24 in balm from Day 11 (baseline) to 18 days.,Change in skin quality parameters post 10 days application of placebo balm from Day 11 (baseline) to 18 days.

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization
 efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the
 elbow and back of forearm in a topical balm format in healthy adults.

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05750381
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05750381 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.